Clinical Trials Browser

Esophageal Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Liver Metastases From Colorectal Cancer (mCRC)

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Adenocarcinoma Of Esophagus, Neoplasm Metastasis, Stomach Neoplasms

Cholangiocarcinoma

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Gallbladder Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Stomach Neoplasms

Small Bowel Adenocarcinoma

Locally Advanced Pancreatic Cancer

Biliary Tract Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Stomach Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Appendiceal Neoplasms, Colorectal Neoplasms

Colonic Neoplasms

Pancreatic Neoplasms

Biliary Tract Neoplasms, Gastrointestinal Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Rectal Neoplasms, Colorectal Neoplasms

Pancreatic Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Pancreatic Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Carcinoma, Pancreatic Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Stomach Neoplasms

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

Gastrointestinal Neoplasms

Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Adenocarcinoma, Neoplasms, Stomach Neoplasms

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma

Colorectal Neoplasms

Stomach Neoplasms

Locally Recurrent Rectal Cancer

Esophageal Neoplasms

Biliary Tract Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms, Peritoneal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Clinical Trials

PROTECT

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

PANCREAS

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

EDGE-Gastric

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

TOGAR

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

TRIPP-FFX

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

ICARuS

ERASE-CRC

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer

CANTOR

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

PANC

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

CEIL

Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer

Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

GRACIE

Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions

ARION

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

ILUSTRO

A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer

DisTinGuish

NIFE

LIVERPEARL

BIG

Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)

Induction Chemotherapy for Locally Advanced Esophageal Cancer

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer

Second-line Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Fruquintinib Versus Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Bevacizumab in Metastatic Colorectal Cancer

COCHISE